Non-inferiority Bioavailabilty Study of 3 Silicon-rich Supplements — BIOSILICI  

Absorption; Disorder Clinical Trial

Official title: Randomized, Crossover, Double Blinded, Non-inferiority Study of Three Products Rich in Organic Silicon, in Postprandrial Situation

Status Completed

Clinical Trial Summary

The objective of the present study is to evaluate the non-inferiority of the absorption parameters of three silicon supplements in human volunteers.

Clinical Trial Description

The objective of the present study is to evaluate the non-inferiority of the absorption parameters of three silicon supplements in human volunteers.

Participants: 5 healthy men over 18 years old, with normal serum creatinine levels. Treatment consists of one product consumption every week, and measuring postprandrial response at 0, 30, 60, 90, 120, 180, 240 and 360 min, in blood, and urine in two periods of three hours each.

The statistical analysis will follow the principles specified in the guidelines of the ICHE and CPMP/EWP/908/99 ICHE Points to Consider on Multiplicity Issues in Clinical Trials. ;

Related Conditions & MeSH terms

• Absorption; Disorder

• NCT number: NCT03108508
• Study type: Interventional
• Source: Technological Centre of Nutrition and Health, Spain
• Status: Completed
• Phase: N/A
• Start date: May 1, 2017
• Completion date: July 30, 2017